FOGAR, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.582
AS - Asia 1.845
EU - Europa 1.625
Continente sconosciuto - Info sul continente non disponibili 18
SA - Sud America 17
OC - Oceania 4
AF - Africa 1
Totale 14.092
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.565
CN - Cina 940
SG - Singapore 658
FI - Finlandia 352
SE - Svezia 251
IT - Italia 241
DE - Germania 219
UA - Ucraina 159
FR - Francia 134
RU - Federazione Russa 124
VN - Vietnam 109
GB - Regno Unito 79
HK - Hong Kong 32
KR - Corea 31
IN - India 27
EU - Europa 18
NL - Olanda 18
IE - Irlanda 17
CA - Canada 14
BR - Brasile 13
JP - Giappone 10
TR - Turchia 8
IR - Iran 7
RO - Romania 7
ES - Italia 6
SI - Slovenia 6
TW - Taiwan 5
AT - Austria 4
BG - Bulgaria 3
ID - Indonesia 3
IL - Israele 3
IQ - Iraq 3
MX - Messico 3
TH - Thailandia 3
AU - Australia 2
BE - Belgio 2
NZ - Nuova Zelanda 2
PE - Perù 2
AR - Argentina 1
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 14.092
Salva come PNG Salva come JPEG
Città #
Fairfield 1.086
Chandler 1.084
Woodbridge 1.057
Ann Arbor 959
Houston 792
Jacksonville 763
Ashburn 689
Wilmington 538
Singapore 484
Cambridge 433
Seattle 369
Boardman 319
Princeton 260
Santa Clara 253
Des Moines 207
Beijing 202
Medford 198
Nanjing 159
Helsinki 135
Dong Ket 109
Roxbury 106
San Diego 92
Guangzhou 63
Nanchang 52
Padova 47
Shenyang 45
Hebei 39
Tianjin 35
New York 34
Hong Kong 31
Changsha 30
Jiaxing 30
Jinan 24
Norwalk 24
Zhengzhou 22
London 20
Gangdong-gu 19
Los Angeles 19
Shanghai 17
Milan 16
Redwood City 16
Dublin 15
Rome 14
Detroit 12
Borås 11
Munich 11
Washington 10
Bologna 9
Indiana 9
Kharkiv 9
Kunming 9
Lanzhou 9
Pune 9
Taizhou 9
Haikou 8
Ningbo 8
Turin 8
Dallas 7
Hangzhou 7
Ogden 7
Rockville 7
Cagliari 6
Falls Church 6
Hefei 6
Kilburn 6
Chengdu 5
Lappeenranta 5
Mestre 5
Montreal 5
Nürnberg 5
San Francisco 5
Yellow Springs 5
Amsterdam 4
Fuzhou 4
Mahon 4
Naples 4
New Delhi 4
Tappahannock 4
Yenibosna 4
Augusta 3
Bucharest 3
Dearborn 3
Florence 3
Frankfurt am Main 3
Genoa 3
Geumjeong-gu 3
Harringay 3
Okazaki 3
Phoenix 3
Saint Petersburg 3
Sofia 3
Taiyuan 3
Tel Aviv 3
Udine 3
Vicenza 3
Vienna 3
Wuhan 3
Ankara 2
Atlanta 2
Baotou 2
Totale 11.212
Salva come PNG Salva come JPEG
Nome #
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma 181
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 180
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 163
Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis. 145
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 140
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 131
ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications 130
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 130
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 128
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 123
Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when? 117
In situ analysis of human menin in normal and neoplastic pancreatic tissues: Evidence for differential expression in exocrine and endocrine cells 117
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 114
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 113
Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases. 112
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 111
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 110
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 110
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 108
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 106
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 106
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 105
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 104
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 104
Does serum CAR-3 play a role in pancreatic cancer diagnosis? 104
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 104
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 103
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 100
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 100
Effect of CagA status on the sensitivity of enzyme immunoassay in diagnosis Helicobacter pylori-infected children 99
Clinical utility of TPS, TPA and CA19-9 measurement in pancreatic cancer 99
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 97
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 97
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 96
Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases. 95
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation 95
Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer 94
Biological variability of lymphocyte subsets of human adults’ blood 93
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 92
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 91
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 90
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 90
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. 89
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 89
Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases. 87
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 87
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 86
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome 85
Helicobacter pylori virulence genes and host IL-1RN and IL-1b genes interplay in favoring the development of peptic ulcer and intestinal metaplasia 84
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblast: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle gene 84
Urinary phospholipase A2 excretion in chronic pancreatic diseases 84
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 83
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. 82
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 81
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 81
Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer. 81
Urinary kallikrein excretion in chronic pancreatic diseases. 81
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 80
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 80
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 80
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 79
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 78
Carcinogenetic potential of the WSR cagA region. 77
Expression profile of pancreatic cancer cell conditioned myoblast: a 5000 muscle genes microarray analysis 77
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 76
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 76
Pancreatic cancer associated diabetogeni peptide induces nitric oxide synthesis in rat hepathocytes 75
NT-S100A8 effects on cell signalling. 75
Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. 75
Gene therapy with HSV-TK: A promising tool for pancreatic cancer treatment? 75
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 74
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 74
Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: state of the art. 74
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 73
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 72
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 72
Retrovirus-mediated herpes simplex virus thymidine kinase gene transfer in pancreatic cancer cell lines: an incomplete antitumor effect 72
A new indirect chemiluminescent immunoassay to measure anti-transglutaminase antibodies: more than a promise 71
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 70
Beta-cell function in pancreatic adenocarcinoma. 70
Predisposizione al cancro del pancreas: ruolo dei polimorfismi dei geni XRCC1, XRCC3 e CYP1A1 69
Suicide gene therapy with the yeast fusion gene Cytosine Deaminase/Uracil Phosphoribosyltransferase is not enough for pancreatic cancer 69
Gastropanel: a useful screening test in paediatric populations 69
Interferon gamma (IFNg) and interleukin-10 (IL-10) Haplotypes differently influence Helicobacter pylori infection outcome 69
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 69
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 69
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 68
Analogues of vitamin E epitomised by alpha-tochopherol succinate (alpha-TOS) for pancreatic cancer treatment: in vitro results induce caution for in vivo applications 68
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 68
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 67
Modulazione termica dell'espressione della subunità  catalitica della tossina difterica e delle sue varianti CRM176 e CRM197 nella terapia genica del carcinoma del pancreas 66
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 65
The pancreatic cancer derived N-terminal peptide of S100A8 stimulates insulin exocytosis and HEPG2 cell growth. 65
CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein? 65
K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA. 65
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 65
Mucopolysaccharidosis type VII diagnosed from a peripheral blood smear 65
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 64
Carcinogenetic potential of the WSR cagA region of Helicobacter pylori. 64
Gene therapy with HSV-TK: a promising tool for pancreatic cancer treatment? 64
Totale 9.049
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.205
article - articoli 23.809
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.014
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.083 0 0 0 0 0 0 0 252 210 334 163 124
2020/20211.549 76 142 71 120 85 109 21 151 210 170 197 197
2021/20221.871 27 368 146 82 60 161 50 143 89 31 185 529
2022/20232.282 438 260 26 267 387 363 8 122 275 26 81 29
2023/20241.088 42 136 111 75 68 176 71 97 27 56 101 128
2024/20251.689 22 234 259 207 652 100 186 29 0 0 0 0
Totale 14.160